국내 성인 세균성 수막염의 임상진료지침 권고안

키워드

참고문헌 (204)

1. Park SA., "Clinical characteristics of meningitis in adults", J Korean Neurol Assoc, 15, pp.1050~1063 (1997)
2. Moon SY., "Changing etiology of community-acquired bacterial meningitis in adults : a nationwide multicenter study in Korea", Eur J Clin Microbiol Infect Dis, 29, pp.793~800 (2010)
3. Chaudhuri A., "EFNS guideline on the management of community-acquired bacterial meningitis : report of an EFNS Task Force on acute bacterial meningitis in older children and adults", Eur J Neurol, 15, pp.649~659 (2008)
4. Tunkel AR., "Practice guidelines for the management of bacterial meningitis", Clin Infect Dis, 39, pp.1267~1284 (2004)
5. Société de pathologie infectieuse de langue française(SPILF)., "Practice guidelines for acute bacterial meningitidis(except newborn and nosocomial meningitis)", Med Mal Infect, 39, pp.356~367 (2009)
6. Begg N., "Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party", J Infect, 39, pp.1~15 (1999)
7. Visintin C., "Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance", BMJ, 340, pp.c3209~ (2010)
8. Horwitz SJ., "Cerebral herniation in bacterial meningitis in childhood", Ann Neurol, 7, pp.524~528 (1980)
9. Korein J., "Reevaluation of lumbar punc ture; a study of 129 patients with papilledema or intracranial hypertension", Neurology, 9, pp.290~297 (1959)
10. Gopal AK., "Cranial computed tomography before lumbar puncture : a prospective clinical evaluation", Arch Intern Med, 159, pp.2681~2685 (1999)
11. Hasbun R., "Computed tomography of the head before lumbar puncture in adults with suspected meningitis", N Engl J Med, 345, pp.1727~1733 (2001)
12. Wylie PA., "Epidemiology and clinical management of meningococcal disease in west Gloucestershire : retrospective, population based study", BMJ, 315, pp.774~779 (1997)
13. Greenlee JE., "Cerebrospinal fluid in CNS infections, In Infections of the central nervous system. 2nd ed", pp.899~922 (1997), Lippincott- Raven
14. Genton B., "Cerebrospinal fluid lactate in 78 cases of adult meningitis", Intensive Care Med, 16, pp.196~200 (1990)
15. Leib SL., "Predictive value of cerebrospinal fluid(CSF)lactate level versus CSF", blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery, 1999, pp.29, 69~74
16. Sakushima K., "Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis : a meta-analysis", J Infect, 62, pp.255~262 (2011)
17. Huy NT., "Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and metaanalysis", Crit Care, 14, pp.R240~ (2010)
18. Gerdes LU., "C-reactive protein and bacterial meningitis : a meta-analysis", Scand J Clin Lab Invest, 58, pp.383~393 (1998)
19. Ray P., "Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear", Am J Emerg Med, 25, pp.179~184 (2007)
20. 박정욱, "성인 뇌수막염 환자들에서 급성기 C-reactive protein 의 예측적 의의", 대한신경과학회지, 21(3), pp.3~254 (2003), 대한신경과학회
21. Gendrel D., "Measurement of procalcitonin levels in children with bacterial or viral meningitis", Clin Infect Dis, 24, pp.1240~1242 (1997)
22. Viallon A., "High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis", Clin Infect Dis, 28, pp.1313~1316 (1999)
23. Schwarz S., "Serum procalcitonin levels in bacterial and abacterial meningitis", Crit Care Med, 28, pp.1828~1832 (2000)
24. Viallon A., "Meningitis in adult patients with a negative direct cerebrospinal fluid examination: value of cytochemical markers for differential diagnosis", Crit Care, 15, pp.R136~ (2011)
25. Tuon FF., "Adenosine deaminase and tuberculous meningitis--a systematic review with meta-analysis", Scand J Infect Dis, 42, pp.198~207 (2010)
26. Moghtaderi A., "Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis", Clin Neurol Neurosurg, 112, pp.459~462 (2010)
27. Sun Q, "Evaluation of Cerebrospinal Fluid Adenosine Deaminase Activity for the Differential Diagnosis of Tuberculous and Nontuberculous Meningitis", Am J Med Sci (2011)
28. Kashyap RS., "Cerebrospinal fluid adenosine deaminase activity : a complimentary tool in the early diagnosis of tuberculous meningitis", Cerebrospinal Fluid Res, 3, pp.5~ (2006)
29. Kim KI., "Studies on adenosine deaminase(ADA)activity in the cerebrospinal fluid of tuberculous meningitis(TBM)", J Korean Neurol Assoc, 16, pp.302~306 (1998)
30. Choi SH., "The possible role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults", Clin Neurol Neurosurg, 104, pp.10~15 (2002)
31. Tunkel AR., "Bacterial meningitis" (2001), Lippincott Williams & Wilkins
32. La Scolea LJ Jr., "Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance", J Clin Microbiol, 19, pp.187~190 (1984)
33. Chapin-Robertson K., "Clinical and laboratory analyses of cytospin-prepared Gram stains for recovery and diagnosis of bacteria from sterile body fluids", J Clin Microbiol, 30, pp.377~380 (1992)
34. Gray LD., "Laboratory diagnosis of bacterial meningitis", Clin Microbiol Rev, 5, pp.130~145 (1992)
35. Mylonakis E., "Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature", Medicine(Baltimore), 77, pp.313~336 (1998)
36. Maxson S., "Clinical usefulness of cerebrospinal fluid bacterial antigen studies", J Pediatr, 125, pp.235~238 (1994)
37. Tarafdar K., "Lack of sensitivity of the latex agglutination test to detect bacterial antigen in the cerebrospinal fluid of patients with culture-negative meningitis", Clin Infect Dis, 33, pp.406~408 (2001)
38. Kim MN., "Utility of latex agglutination test in the laboratory diagnosis of bacterial meningitis", Korean J Clin Pathol, 18, pp.584~590 (1998)
39. Ni H., "Polymerase chain reaction for diagnosis of meningococcal meningitis", Lancet, 340, pp.1432~1434 (1992)
40. Rådström P., "Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy", J Clin Microbiol, 32, pp.2738~2744 (1994)
41. Chiba N., "Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR", J Infect Chemother, 15, pp.92~98 (2009)
42. Welinder-Olsson C., "Comparison of broad-range bacterial PCR and culture of cerebrospinal fluid for diagnosis of community-acquired bacterial meningitis", Clin Microbiol Infect, 13, pp.879~886 (2007)
43. Fukui MB., "CT and MR imaging features of pyogenic ventriculitis", AJNR Am J Neuroradiol, 22, pp.1510~1516 (2001)
44. Kamran S., "Role of fluidattenuated inversion recovery in the diagnosis of meningitis : comparison with contrast-enhanced magnetic resonance imaging", J Comput Assist Tomogr, 28, pp.68~72 (2004)
45. Han KT., "Diffusion-weighted MR imaging of pyogenic intraventricular empyema", NEURORADIOLOGY, 49, pp.813~818, SPRINGER
46. Katchanov J., "Focal parenchymal lesions in community-acquired bacterial meningitis in adults : a clinico-radiological study", Neuroradiology, 51, pp.723~729 (2009)
47. Teixeira J., "Diffusion imaging in pediatric central nervous system infections", Neuroradiology, 43, pp.1031~1039 (2001)
48. Wong AM., "Diffusion-weighted MR imaging of subdural empyemas in children", Am J Neuroradiol, 25, pp.1016~1021 (2004)
49. kaplan SL., "Management of pneumococcal infections", Pediatr Infect Dis J, 21, pp.589~591 (2002)
50. Kaplan SL., "Management of infections due to antibiotic-resistant Streptococcus pneumoniae", Clin Microbiol Rev, 11, pp.628~644 (1998)
51. Feldman WE., "Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis", J Pediatr, 100, pp.209~212 (1982)
52. Schaad UB., "A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children", N Engl J Med, 322, pp.141~147 (1990)
53. Aronin SI., "Community-acquired bacterial meningitis : risk stratification for adverse clinical outcome and effect of antibiotic timing", Ann Intern Med, 129, pp.862~869 (1998)
54. Proulx N., "Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis", QJM, 98, pp.291~298 (2005)
55. Lepur D., "Community-acquired bacterial meningitis in adults : antibiotic timing in disease course and outcome", Infection, 35, pp.225~231 (2007)
56. Lu CH., "Community-acquired bacterial meningitis in adults : the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors", Clin Neurol Neurosurg, 104, pp.352~358 (2002)
57. Miner JR., "Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center", J Emerg Med, 21, pp.387~392 (2001)
58. Park DC., "Acute bacterial meningitis : causative organisms, clinical characteristics and prognosis", J Korean Neurol Assoc, 18, pp.556~561 (2000)
59. Kim SH., "Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries : an Asian Network for Surveillance of Resistant Pathogens(ANSORP)study", Antimicrob Agents Chemother, 56, pp.1418~1426 (2012)
60. Sang-OhLee, "Meningococcal Disease in the Republic of Korea Army: Incidence and Serogroups Determined by PCR", Journal of Korean Medical Science, 18(2), pp.163~166 (2003), 대한의학회
61. Choi JM., "Ventriculostomy-associated infection : analysis of risk factors and the venue of external ventricular drainage", Korean J Cerebrovasc Surg, 9, pp.55~59 (2007)
62. Friedland IR., "Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis", Lancet, 339, pp.405~408 (1992)
63. Friedland IR., "Management of infections caused by antibiotic-resistant Streptococcus pneumoniae", N Engl J Med, 331, pp.377~382 (1994)
64. Leggiadro RJ., "Penicillin-and cephalosporin-resistant Streptococcus pneumoniae : an emerging microbial threat", Pediatrics, 93, pp.500~503 (1994)
65. McMaster P., "The emergence of resistant pneumococcal meningitis--implications for empiric therapy", Arch Dis Child, 87, pp.207~210 (2002)
66. Quagliarello VJ., "Treatment of bacterial meningitis", N Engl J Med, 336, pp.708~716 (1997)
67. Sáez-Llorens X., "Quinolone treatment for pediatric bacterial meningitis : a comparative study of trovafloxacin and ceftriaxone with or without vancomycin", Pediatr Infect Dis J, 21, pp.14~22 (2002)
68. Sáez-Llorens X., "Cefepime in the empiric treatment of meningitis in children", Pediatr Infect Dis J, 20, pp.356~361 (2001)
69. Scholz H., "Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children", Chemotherapy, 44, pp.142~147 (1998)
70. Theilen U., "Management of invasive meningococcal disease in children and young people : summary of SIGN guidelines", BMJ, 336, pp.1367~1370 (2008)
71. Anonymous., "Therapy for children with invasive pneumococcal infections. American Academy of Pediatrics Committee on Infectious Diseases", Pediatrics, 99, pp.289~299 (1997)
72. Bae S., "Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea : results of a nationwide acute respiratory infections surveillance", Antimicrob Agents Chemother, 54, pp.65~71 (2010)
73. Lebel MH., "Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis", J Pediatr, 114, pp.1049~1054 (1989)
74. Peltola H., "Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group", Lancet, 1, pp.1281~1287 (1989)
75. Sudo F., "Successful treatment of beta-lactamase-negative ampicillinresistant Haemophilus influenzae type b meningitis with high-dose ceftriaxone administration", Kansenshogaku Zasshi, 78, pp.604~608 (2004)
76. Cherubin CE., "Treatment of gram-negative bacillary meningitis: role of the new cephalosporin antibiotics", Rev Infect Dis, 4(Suppl), pp.S453~S464 (1982)
77. Kaplan SL., "Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms", Pediatr Infect Dis J, 9, pp.810~814 (1990)
78. Landesman SH., "Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis", Am J Med, 71, pp.693~703 (1981)
79. Fong IW., "Review of Pseudomonas aeruginosa meningitis with special emphasis on treatment with ceftazidime", Rev Inf Dis, 7, pp.604~612 (1985)
80. Rodriguez WJ., "Treatment of Pseudomonas meningitis with ceftazidime with or without concurrent therapy", Pediatr Infect Dis J, 9, pp.83~87 (1990)
81. Saez-Llorens X., "Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children", Antimicrob Agents Chemother, 39, pp.937~940 (1995)
82. Lodise TP Jr., "Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae", Diagn Microbiol Infect Dis, 58, pp.445~452 (2007)
83. Rousseau JM., "Efficiency of cefepime in postoperative meningitis attributable to Enterobacter aerogenes", J Trauma, 50, pp.971~ (2001)
84. Ahmed A., "A critical evaluation of vancomycin for treatment of bacterial meningitis", Pediatr Infect Dis J, 16, pp.895~903 (1997)
85. Viladrich PF., "Evaluation of vancomycin for therapy of adult pneumococcal meningitis", Antimicrob Agents Chemother, 35, pp.2467~2472 (1991)
86. Böttcher T., "Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis", J Infect Dis, 181, pp.2095~2098 (2000)
87. Nau R., "Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis", J Infect Dis, 179, pp.1557~1560 (1999)
88. Spreer A., "Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis", Crit Care Med, 37, pp.2253~2258 (2009)
89. Aguilar J., "Staphylococcus aureus meningitis : case series and literature review", Medicine(Baltimore), 89, pp.117~125 (2010)
90. Al Kandari M., "A case of community-onset meningitis caused by hospital methicillin-resistant Staphylococcus aureus successfully treated with linezolid and rifampicin", Med Princ Pract, 19, pp.235~239 (2010)
91. Kaufman BA., "Infections of cerebrospinal fluid shunts, In Infections of the central nervous system, 2nd ed", pp.555~577 (1997), Lippincott-Raven
92. Orvin K., "Successful antibiotic eradication of Streptococcus pneumoniae infection of a ventriculoatrial shunt", Int J Infect Dis, 13, pp.e101~e103 (2009)
93. Bradley JS., "The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s", Clin Infect Dis, 24(Suppl 2), pp.S213~S221 (1997)
94. Force E., "Experimental study of meropenem in the therapy of cephalosporin-susceptible and-resistant pneumococcal meningitis", Eur J Clin Microbiol Infect Dis, 27, pp.685~690 (2008)
95. Force E., "Evaluation of meropenem alone and combined with rifampin in the guinea pig model of pneumococcal meningitis", Eur J Clin Microbiol Infect Dis, 28, pp.807~811 (2009)
96. John CC., "Successful meropenem treatment of multiply resistant pneumococcal meningitis", Pediatr Infect Dis J, 16, pp.1009~1011 (1997)
97. Odio CM., "Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group", Pediatr Infect Dis J, 18, pp.581~590 (1999)
98. Schmutzhard E., "A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group", J Antimicrob Chemother, 36(Suppl A), pp.85~97 (1995)
99. Buckingham SC., "Pneumococcal susceptibility to meropenem in a mid-south children's hospital", South Med J, 95, pp.1293~1296 (2002)
100. Chmelik V., "Meropenem treatment of post-traumatic meningitis due to Pseudomonas aeruginosa", J Antimicrob Chemother, 32, pp.922~923 (1993)
101. Nicasio AM., "Treatment of Serratia marcescens meningitis with prolonged infusion of meropenem", Ann Pharmacother, 41, pp.1077~1081 (2007)
102. Segal-Maurer S., "Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B : case report and review", Clin Infect Dis, 28, pp.1134~1138 (1999)
103. Asensi F., "Risk", benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus, 1993, pp.5, 133~134
104. Asensi F., "Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus", Pediatr Infect Dis J, 8, pp.895~ (1989)
105. Rodriguez K., "Successful treatment of gram-negative bacillary meningitis with imipenem", cilastatin, 1985, pp.78, 731~732
106. Cottagnoud P., "Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or-resistant pneumococci in experimental meningitis", Antimicrob Agents Chemother, 47, pp.1943~1947 (2003)
107. Cottagnoud PH., "New therapies for pneumococcal meningitis", Expert opin Investig Drugs, 13, pp.393~401 (2004)
108. Schonwald S., "Ciprofloxacin in the treatment of gram-negative bacillary meningitis", Am J Med, 87, pp.248S~249S (1989)
109. Djukic M., "Moxifloxacin in experimental Streptococcus pneumoniae cerebritis and meningitis", Neurocrit Care, 2, pp.325~329 (2005)
110. Krcméry V Jr., "Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants : report of 12 cases and review", Diagn Microbiol Infect Dis, 35, pp.75~80 (1999)
111. Lipman J., "Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis", Clin Infect Dis, 31, pp.1131~1133 (2000)
112. Lo WT., "Successful treatment of multi-resistant Stenotrophomonas maltophilia meningitis with ciprofloxacin in a pre-term infant", Eur J Pediatr, 161, pp.680~682 (2002)
113. Wong-Beringer A., "Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with high-dose ciprofloxacin", Clin Infect Dis, 25, pp.936~937 (1997)
114. Graninger W., "Clinical applications of levofloxacin for severe infections", Chemotherapy, 50(Suppl 1), pp.16~21 (2004)
115. Rodriguez-Cerrato V., "Garenoxacin(BMS-284756)and moxifloxacin in experimental meningitis caused by vancomycintolerant pneumococci", Antimicrob Agents Chemother, 47, pp.211~215 (2003)
116. Schmidt H., "Moxifloxacin in the therapy of experimental pneumococcal meningitis", Antimicrob Agents Chemother, 42, pp.1397~1407 (1998)
117. Beer R., "Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains", Antimicrob Agents Chemother, 51, pp.379~382 (2007)
118. Destache CJ., "Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model", J Antimicrob Chemother, 47, pp.611~615 (2001)
119. Nau R., "Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits", Antimicrob Agents Chemother, 39, pp.593~597 (1995)
120. Pea F., "Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy", Antimicrob Agents Chemother, 47, pp.3104~3108 (2003)
121. Scotton PG., "Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis", Clin Infect Dis, 33, pp.e109~e111 (2001)
122. Ergaz Z., "Elimination of vancomycin-resistant enterococci from a neonatal intensive care unit following an outbreak", J Hosp Infect, 74, pp.370~376 (2010)
123. Gattuso G., "A case of community-acquired MRSA(CA-MRSA)sepsis complicated by meningoencephalitis and cerebral abscess, successfully treated with linezolid", Infez Med, 17, pp.244~248 (2009)
124. Hameed N., "Treatment of drug-resistant pneumococcal meningitis", Curr Infect Dis Rep, 12, pp.274~281 (2010)
125. Cottagnoud P., "Linezolid against penicillin-sensitive and-resistant pneumococci in the rabbit meningitis model", J Antimicrob Chemother, 46, pp.981~985 (2000)
126. Ramírez P., "Linezolid as rescue therapy for pneumococcal meningitis", Intensive Care Med, 33, pp.924~925 (2007)
127. Stahl JP., "Treatment of community acquired bacterial meningitis, after microbiological identification", Med Mal Infect, 39, pp.513~520 (2009)
128. Cottagnoud P., "Daptomycin is highly efficacious against penicillin-resistant and penicillin-and quinoloneresistant pneumococci in experimental meningitis", Antimicrob Agents Chemother, 48, pp.3928~3933 (2004)
129. Egermann U., "Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone", Antimicrob Agents Chemother, 53, pp.3030~3033 (2009)
130. Gerber P., "Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis", J Antimicrob Chemother, 57, pp.720~723 (2006)
131. Grandgirard D., "Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis", Antimicrob Agents Chemother, 54, pp.1323~1326 (2010)
132. Grandgirard D., "Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis", Antimicrob Agents Chemother, 51, pp.2173~2178 (2007)
133. Mook-Kanamori BB., "Daptomycin in experimental murine pneumococcal meningitis", BMC Infect Dis, 9, pp.50~ (2009)
134. choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall, "Antimicrob Agents Chemother", 2007, 2249~2252
135. Ellis-Pegler R., "Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults", Clin Infect Dis, 37, pp.658~662 (2003)
136. Martin E., "Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children : results of a Swiss multicenter study. Part I : Clinical results", Infection, 18, pp.70~77 (1990)
137. Roine I., "Randomized trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery", Pediatr Infect Dis J, 19, pp.219~222 (2000)
138. Singhi P., "Seven days vs. 10 days ceftriaxone therapy in bacterial meningitis", J Trop Pediatr, 48, pp.273~279 (2002)
139. Lin TY., "Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis", JAMA, 253, pp.3559~3563 (1985)
140. Marks WA., "Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis : a multicenter randomized controlled trial", J Pediatr, 109, pp.123~130 (1986)
141. Hervas JA., "Nonneonatal relapsing meningitis caused by Listeria monocytogenes", Pediatr Infect Dis, 5, pp.721~ (1986)
142. Niklasson PM., "Listeria encephalitis in five renal transplant recipients", Acta Med Scand, 203, pp.181~185 (1978)
143. Scheer MS., "Oral and ambulatory therapy of Listeria bacteremia and meningitis with trimethoprimsulfamethoxazole", Mt Sinai J Med, 49, pp.411~414 (1982)
144. Lu CH., "The prognostic factors of adult gram-negative bacillary meningitis", J Hosp Infect, 40, pp.27~34 (1998)
145. Mancebo J., "Postneurosurgical and spontaneous gram-negative bacillary meningitis in adults", Scand J Infect Dis, 18, pp.533~538 (1986)
146. O'Neill E., "Thirdgeneration cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients : significant challenges in ensuring effective antibiotic therapy", J Antimicrob Chemother, 57, pp.356~359 (2006)
147. van de Beek D., "Clinical features and prognostic factors in adults with bacterial meningitis", N Engl J Med, 351, pp.1849~1859 (2004)
148. van de Beek D., "Communityacquired bacterial meningitis in adults", N Engl J Med, 354, pp.44~53 (2006)
149. van de Beek D., "Cognitive impairment in adults with good recovery after bacterial meningitis", J Infect Dis, 186, pp.1047~1052 (2002)
150. Weisfelt M., "Pneumococcal meningitis in adults : new approaches to management and prevention", Lancet Neurol, 5, pp.332~342 (2006)
151. McIntyre PB., "Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988", JAMA, 278, pp.925~931 (1997)
152. van de Beek D., "Corticosteroids in acute bacterial meningitis", Cochrane Database Syst Rev, pp.CD004405~ (2003)
153. de Gans J., "Dexamethasone in adults with bacterial meningitis", N Engl J Med, 347, pp.1549~1556 (2002)
154. Cabellos C., "Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis", J Antimicrob Chemother, 45, pp.315~320 (2000)
155. Klugman KP., "Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis", Antimicrob Agents Chemother, 39, pp.1988~1992 (1995)
156. Ricard JD., "Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis : a prospective multicenter observational study", Clin Infect Dis, 44, pp.250~255 (2007)
157. Nguyen TH., "Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis", N Engl J Med, 357, pp.2431~2440 (2007)
158. Scarborough M., "Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa", N Engl J Med, 357, pp.2441~2450 (2007)
159. Brouwer MC., "Corticosteroids for acute bacterial meningitis", Cochrane Database Syst Rev, pp.CD004405~ (2010)
160. Moon SY., "Is adjunctive corticosteroid beneficial in pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone?", J Neurol (2012)
161. Nadel S., "Diagnosis and management of meningococcal disease : the need for centralized care", FEMS Microbiol Rev, 31, pp.71~83 (2007)
162. Kilpi T., "Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group", Pediatr Infect Dis J, 14, pp.270~278 (1995)
163. Lorenzl S., "Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat", Crit Care Med, 24, pp.1874~1880 (1996)
164. Peltola H., "Adjuvant glycerol and", or dexamethasone to improve the outcomes of childhood bacterial meningitis : a prospective, randomized, double-blind, placebo-controlled trial, 2007, pp.45, 1277~1286
165. Singhi S., "Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis", Pediatr Infect Dis J, 27, pp.892~896 (2008)
166. Syrogiannopoulos GA., "Mannitol treatment in experimental Haemophilus influenzae type b meningitis", Pediatr Res, 22, pp.118~122 (1987)
167. Minns RA., "Cerebrospinal fluid pressure in pyogenic meningitis", Arch Dis Child, 64, pp.814~820 (1989)
168. 남상욱, "소아에서 중추 신경계 감염 후 발생한 간질의 위험 인자", 대한소아신경학회지, 18(1), pp.33~39 (2010), 대한소아신경학회
169. Cabellos C., "Community-acquired bacterial meningitis in elderly patients : experience over 30 years", Medicine(Baltimore), 88, pp.115~119 (2009)
170. Chang CJ., "Seizures complicating infantile and childhood bacterial meningitis", Pediatr Neurol, 31, pp.165~171 (2004)
171. Wang KW., "The significance of seizures and other predictive factors during the acute illness for the long-term outcome after bacterial meningitis", Seizure, 14, pp.586~592 (2005)
172. Zoons E., "Seizures in adults with bacterial meningitis", Neurology, 70, pp.2109~2115 (2008)
173. Bianchetti MG., "Evidence for fluid volume depletion in hyponatraemic patients with bacterial meningitis", Acta Paediatr, 85, pp.1163~1166 (1996)
174. Singhi SC., "Fluid restriction does not improve the outcome of acute meningitis", Pediatr Infect Dis J, 14, pp.495~503 (1995)
175. Tauber MG., "Fluid administration, brain edema, and cerebrospinal fluid lactate and glucose concentrations in experimental Escherichia coli meningitis", J Infect Dis, 168, pp.473~476 (1993)
176. Ziai WC., "Improving the role of intraventricular antimicrobial agents in the management of meningitis", Curr Opin Neurol, 22, pp.277~282 (2009)
177. Kestle JR., "Management of shunt infections: a multicenter pilot study", J Neurosurg, 105(3 Suppl), pp.177~181 (2006)
178. Tunkel AR., "Cerebrospinal fluid shunt infections, In Principles and Practice of Infectious Diseases. 6 ed", pp.1126~1132 (2005), Elsevier Inc
179. Bilukha OO., "Recommendations of the Advisory Committee on Immunization Practices(ACIP)", MMWR Recomm Rep, 54, pp.1~21 (2005)
180. Korea Centers for Disease Control and Prevention., "Current status of selected infectious diseases", Public Health Weekly Report, 4, pp.961~967 (2012)
181. Kristiansen BE., "Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis?. A population based study", BMJ, 317, pp.621~625 (1998)
182. Anonymous., "Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974", JAMA, 235, pp.261~265 (1976)
183. Anonymous., "Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis", J Infect Dis, 134, pp.201~204 (1976)
184. De Wals P., "Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and preelementary school contacts", J Infect, 3(1 Suppl), pp.53~61 (1981)
185. Purcell B., "Effectiveness of antibiotics in preventing meningococcal disease after a case : systematic review", BMJ, 328, pp.1339~ (2004)
186. Jacobson JA., "Meningococcal disease in day-care centers", Pediatrics, 59, pp.299~300 (1977)
187. Anonymous., "Control of meningococcal disease: guidance for consultants in communicable disease control. PHLS Meningococcal Infections Working Group and Public Health Medicine Environmental Group", Commun Dis Rep CDR Rev, 5, pp.R189~195 (1995)
188. "Guidelines for the management of airline passengers exposed to meningococcal disease" (2000)[URL]
189. Edwards EA., "Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence", Scand J Infect Dis, 9, pp.105~110 (1977)
190. Gardner P., "Clinical practice. Prevention of meningococcal disease", N Engl J Med, 355, pp.1466~1473 (2006)
191. Dworzack DL., "Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers", Antimicrob Agents Chemother, 32, pp.1740~1741 (1988)
192. Schwartz B., "Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis", Lancet, 1, pp.1239~1242 (1988)
193. Gaunt PN., "Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis", J Antimicrob Chemother, 21, pp.489~496 (1988)
194. Girgis N., "Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis", Pediatr Infect Dis J, 17, pp.816~819 (1998)
195. Pittman M., "Variation and type specificcity in the bacterial species Hemophilus influenzae", J Exp Med, 53, pp.471~492 (1931)
196. Peltola H., "Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century : global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates", Clin Microbiol Rev, 13, pp.302~317 (2000)
197. 조혜경, "The Causative Organisms of Bacterial Meningitis in Korean Children in 1996-2005", Journal of Korean Medical Science, 25(6), pp.895~899 (2010), 대한의학회
198. Kim KH., "The causative organisms of bacterial meningitis in Korean children, 1986-1995", J Korean Med Sci, 13, pp.60~64 (1998)
199. Goldwater PN., "Effect of cefotaxime or ceftriaxone treatment on nasopharyngeal Haemophilus influenzae type b colonization in children", Antimicrob Agents Chemother, 39, pp.2150~2152 (1995)
200. Ladhani S., "Recommendations for the prevention of secondary Haemophilus influenzae type b(Hib)disease", J Infect, 58, pp.3~14 (2009)
201. Sumaraju V., "Infectious complications in asplenic hosts", Infect Dis Clin North Am, 15, pp.551~565 (2001)
202. Ward JI., "Haemophilus influenzae meningitis. A national study of secondary spread in household contacts", N Engl J Med, 301, pp.122~126 (1979)
203. Cox F., "Rifampin prophylaxis for contacts of Haemophilus influenzae type b disease", JAMA, 245, pp.1043~1045 (1981)
204. McVernon J., "Long-term impact of vaccination on Haemophilus influenzae type b(Hib)carriage in the United Kingdom", Epidemiol Infect, 132, pp.765~767 (2004)